Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

AXA Add to portfolio

STX:CS, Nov 21, 04:22 UTC

Latest STX:CS News

Filter your feed

Apply Filter

Tuesday, November 19


News

AXA Insurance to underwrite THB’s Fleet UK product

CS

Get breaking news alerts, daily news and analysis email summary and on-depth special reports on key trends and developments. The insurance plan clubs risk management services provided by THB’s Cardinus Risk Management with road safety telematics and fleet analysis offered by Drive. Fleet UK managing director Glen McCully said: “Fleet UK remains a premier fleet product for risk-managed fleets of all sizes.“With AXA as our new partner from 1 January and the full risk management backing of Cardinus and Driive, we’re excited that we can continue to offer this excellent product.“Our new partnership with AXA gives us the opportunity to refresh our commitment to this quality motor fleet proposition for our brokers, with whom we have forged strong relationships over the years.”AXA Insurance head of casualty insurance, fleet and motor trade Steve Browne stated: “The Fleet UK product, through its real-time service, offers the opportunity to discuss individual risks in detail and fits perfectly with our ‘payer to partner’ strategy, allowing us to bring our safety and risk management expertise to bear.”Last month, AXA launched an online travel health calculator tool that enables travellers with pre-existing medical conditions to calculate their health insurance premiums. Digital editions are here to cover some of the key trends and developments across the industry.

Read Full Details

Topics:
  • Business
  • Financial
  • Science
News

Axa SA (EPA:CS) Given Average Recommendation of “Buy” by Brokerages – TechNewsObserver

CS

Shares of Axa SA (EPA:CS) have been given a consensus rating of “Buy” by the twelve research firms that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. Royal Bank of Canada set a €29.50 ($34.30) target price on AXA and gave the stock a “buy” rating in a report on Wednesday, July 31st. Nord/LB set a €27.00 ($31.40) target price on AXA and gave the stock a “buy” rating in a report on Tuesday, August 27th. AXA has a 1-year low of €22.13 ($25.73) and a 1-year high of €27.69 ($32.20).

Read Full Details

Topics:
  • Business
  • Financial

Monday, November 18


News

AXA boosts spending on AI, data analytics in Hong Kong as health revenues power growth in Asian business

CS

AXA boosts spending on AI, data analytics in Hong Kong as health revenues power growth in Asian business. AXA SA is stepping up its investment in artificial intelligence and data analytics in Hong Kong to improve health outcomes and lower medical costs, latching on to the city's proximity to many technological advancements in mainland China. The insurer expects to spend HK$220 million on technology, such as AI and big data applications by the end of this year, a 10 per cent increase from 2018, according to Ashok Krishnan, chief data officer and head of customer experience at the local unit of the Paris-based insurance group. High-level of smartphone and social media usage, as well as access to new technologies being developed in China, make Hong Kong a "a very interesting" test-bed for new AI and data analytics tools, he added.

Read Full Details

Topics:
  • Business
  • Health
  • Financial

Wednesday, November 13


News

Former Chief Executive of AXA PPP healthcare Keith Gibbs joins advisory board at Cognetivity Neurosciences

CS

VANCOUVER , Nov. 13, 2019 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced the appointment of Keith Gibbs , former Chief Executive of AXA PPP healthcare, to its advisory board with immediate effect. Between 2002 and 2018, Gibbs also sat on the council of the International Federation of Health Plans (iFHP), the leading CEO network within the global health insurance industry, spending three years as chairman. "Given the length of his tenure in senior leadership at AXA, few can match his understanding of the health insurance industry or the strength and breadth of his connections. His recent appointments and continued non-executive directorship at AXA demonstrate the high esteem in which he is held in the industry." "By bringing a fresh, client perspective," Habibi continued, "he is the perfect person to help us develop our customer network and tailor our offering to meet the specific needs of the health insurance and healthcare provider industries. As such, his involvement represents a significant step in our commercial rollout plan."

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

AXA (EPA:CS) Given a €29.00 Price Target at Goldman Sachs Group – TechNewsObserver

GS CS

AXA (EPA:CS) has been assigned a €29.00 ($33.72) price objective by equities researchers at Goldman Sachs Group in a research report issued on Wednesday, Borsen Zeitung reports. Goldman Sachs Group’s price objective indicates a potential upside of 14.58% from the company’s current price. Finally, JPMorgan Chase & Co. set a €26.90 ($31.28) price objective on AXA and gave the stock a “buy” rating in a research note on Wednesday, November 6th. AXA presently has a consensus rating of “Buy” and a consensus target price of €26.95 ($31.34).

Read Full Details

Topics:
  • Business
  • Financial

Sunday, November 10


News

Goldman Sachs Group Analysts Give AXA (EPA:CS) a €27.50 Price Target – TechNewsObserver

CS

AXA (EPA:CS) received a €27.50 ($31.98) target price from Goldman Sachs Group in a report issued on Friday, October 18th, Borsen Zeitung reports. Deutsche Bank set a €25.00 ($29.07) price objective on shares of AXA and gave the stock a “buy” rating in a research note on Friday, August 2nd. Nord/LB set a €27.00 ($31.40) price target on shares of AXA and gave the company a “buy” rating in a research note on Tuesday, August 27th. 11,495,961 shares of the company’s stock were exchanged, compared to its average volume of 9,520,000. AXA has a twelve month low of €22.13 ($25.73) and a twelve month high of €27.69 ($32.20).

Read Full Details

Topics:
  • Business
  • Financial

Saturday, November 09


News

AXA expects to book $3.1 billion gain from EQH exit

TRI CS

AXA expects to book $3.1 billion gain from EQH exit. (Reuters) - French insurer AXA (AXAF.PA) said it expected to book net proceeds of $3.1 billion from the sale of a 29% stake in AXA Equitable Holdings (EQH) (EQH.N) as it exits its U.S. life insurance business. AXA, the second-largest European insurer after Germany's Allianz (ALVG.DE), has been gradually divesting from EQH to raise funds to pay for its $15 billion acquisition of Bermuda-based rival XL last year. AXA said in a statement on Friday it had sold 144 million EQH shares at $21.80 per share to Goldman Sachs (GS.N), the sole underwriter in a secondary public share offering expected to close on Nov. 13.

Read Full Details

Topics:
  • Business
  • Financial

Friday, November 08


News

AXA Equitable's stock rises on heavy volume; largest shareholder to sell off 144 million shares

CS

AXA Equitable Holdings Inc.'s stock stood out Friday for a change, as the most actively traded on major U.S. exchanges, after the financial services company disclosed that its largest shareholder was slashing its stake by selling off 144 million shares. AXA Equitable's stock rose 3.7% in midday trading, to trade above the Sept. 4, 2018 record closing price of $23.03. Volume swelled to 34.3 million shares, compared with the full-day average of about 2.2 million shares. The company said in a filing late Thursday that France-based insurer AXA S.A. was selling 144 million shares, which will reduce AXA's stake in AXA Equitable to 47.2 million shares, or 10.1% of the shares outstanding, from 191.2 million shares, or 39.1% of the shares outstanding.

Read Full Details

Topics:
  • Business
  • Financial
News

AXA (EPA:CS) Given a €24.30 Price Target at Barclays – TechNewsObserver

CS JEF

CS has been the topic of a number of other research reports. UBS Group set a €22.00 ($25.58) price objective on shares of AXA and gave the stock a neutral rating in a research report on Monday, September 9th. Nord/LB set a €27.00 ($31.40) target price on shares of AXA and gave the stock a buy rating in a report on Tuesday, August 27th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. AXA has a 12 month low of €22.13 ($25.73) and a 12 month high of €27.69 ($32.20).

Read Full Details

Topics:
  • Business
  • Financial

Thursday, November 07


News

AXA Equitable Holdings, Inc. Announces Sale of 144,000,000 Shares of Common Stock by AXA S.A.

GS CS

Goldman Sachs proposes to offer for sale the shares of common stock from time to time in one or more transactions on the New York Stock Exchange, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, subject to receipt and acceptance by it and subject to its right to reject any order in whole or in part. As part of the offering, the sole underwriter has reserved 24,000,000 of the 144,000,000 shares of common stock which the Company has agreed to repurchase. The Company’s share repurchase is pursuant to its previously announced share repurchase program. Investors should read the prospectus in that registration statement and other documents the Company has filed with the SEC before investing for more complete information about the Company and this offering. These documents are available for free by searching for the Company’s public filings on the SEC’s website at www.sec.gov, or by visiting the Company’s website at https://ir.axaequitableholdings.com.

Read Full Details

Topics:
  • Business
  • Financial